368 related articles for article (PubMed ID: 32418883)
21. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
22. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
[TBL] [Abstract][Full Text] [Related]
23. Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves.
Fischer Q; Urena M; Bouleti C; Abtan J; Brochet E; Carrasco JL; Iung B; Vahanian A; Himbert D
Arch Cardiovasc Dis; 2019; 112(8-9):512-522. PubMed ID: 31474571
[TBL] [Abstract][Full Text] [Related]
24. Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
Durand E; Beziau-Gasnier D; Michel M; Iung B; Tchetche D; Bonnet G; Lhermusier T; Gilard M; Souteyrand G; Bouleti C; Ohlmann P; Lefevre T; Beygui F; Chassaing S; Chevreul K; Eltchaninoff H; ;
Eur Heart J; 2024 Mar; 45(11):952-962. PubMed ID: 38437633
[TBL] [Abstract][Full Text] [Related]
25. Vascular access site complications after transfemoral transcatheter aortic valve implantation in the POL-TAVI Registry: surgical versus percutaneous approach.
Walas RL; Kukulski L; Rychter J; Jaźwiec T; Gąska M; Hawranek M; Zembala M; Gąsior M; Zembala MO
J Cardiovasc Surg (Torino); 2020 Feb; 61(1):117-122. PubMed ID: 31815374
[TBL] [Abstract][Full Text] [Related]
26. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay.
Lauck SB; Wood DA; Baumbusch J; Kwon JY; Stub D; Achtem L; Blanke P; Boone RH; Cheung A; Dvir D; Gibson JA; Lee B; Leipsic J; Moss R; Perlman G; Polderman J; Ramanathan K; Ye J; Webb JG
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):312-21. PubMed ID: 27116975
[TBL] [Abstract][Full Text] [Related]
27. Left Bundle Branch Block after Transcatheter Aortic Valve Implantation with Edwards Sapien 3 Valve: Influence of the Valve Depth Implantation.
Unzué L; García E; Díaz-Antón B; Rodríguez-Rodrigo FJ; Rodríguez Del Río M; Teijeiro R; Medina J; Parra FJ
Cardiovasc Revasc Med; 2019 Nov; 20(11):949-955. PubMed ID: 30745060
[TBL] [Abstract][Full Text] [Related]
28. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
[TBL] [Abstract][Full Text] [Related]
29. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
[TBL] [Abstract][Full Text] [Related]
30. Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry.
Butter C; Okamoto M; Schymik G; Jacobshagen C; Rothe J; Treede H; Kerber S; Frank D; Bramlage P; Sykorova L; Thoenes M; Rudolph TK
Catheter Cardiovasc Interv; 2019 Sep; 94(3):469-478. PubMed ID: 30866154
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
[TBL] [Abstract][Full Text] [Related]
33. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.
Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H
Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810
[TBL] [Abstract][Full Text] [Related]
34. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
35. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
36. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
37. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
[TBL] [Abstract][Full Text] [Related]
38. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Analysis of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation.
Serletis-Bizios A; Durand E; Cellier G; Tron C; Bauer F; Glinel B; Dacher JN; Cribier A; Eltchaninoff H
Am J Cardiol; 2016 Sep; 118(6):866-872. PubMed ID: 27453514
[TBL] [Abstract][Full Text] [Related]
40. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
